December 01, 2022 | 13:00
Multinational corporations in Vietnam are expecting changes in drug rules to make more business and investment progress. Tran Ngoc Anh, representative of the US-ASEAN Business Council, discussed with VIR’s Bich Thuy the current barriers and expectations stemming from legal adjustments.
July 27, 2022 | 10:36
The introduction of a global minimum corporate tax on the foreign profits of multinational corporations will affect Vietnam’s own tax plans. Annett Perschmann-Taubert, tax partner at PwC Vietnam, discussed with VIR’s Luu Huong the current tax landscape and how policies should be reformed in order to maintain momentum.
July 10, 2022 | 15:40
Capital reallocation plans announced by multinational corporations will offer opportunities for Vietnam to attract foreign direct investment, experts said.
December 31, 2021 | 14:34
While keeping strong business and investment plans in Vietnam, multinational corporations continue to seek more favourable timelines for innovative pharma registration to further facilitate future expansions.
November 18, 2021 | 17:00
A number of multinational corporations are planning to venture further into local production to enjoy incentives and to benefit from the landmark EU-Vietnam Free Trade Agreement.
March 11, 2020 | 11:00
Facing significant expansion from multinational corporations, Vietnamese drug giants took a hit in 2019 despite new strategies, signalling an uninspiring outlook for future growth.